Riva Sheppard - 25 May 2023 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Signature
/s/ Riva Sheppard
Issuer symbol
INBP
Transactions as of
25 May 2023
Net transactions value
+$1,368,705
Form type
4
Filing time
21 Sep 2023, 16:17:45 UTC
Previous filing
10 Nov 2022
Next filing
01 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBP Common Stock Award $1,364,205 +3,410,512 +21723% $0.4000 3,426,212 25 May 2023 As Co-Executor of the Estate of E Gerald Kay and as Trustee of the Emily Sheppard Trust F1, F2, F3
transaction INBP Common Stock Award $4,500 +50,000 +4.1% $0.0900* 1,273,467 20 Sep 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Award $0 +150,000 $0.000000 150,000 25 May 2023 Common Stock 150,000 $0.2300 As Co-Executor of the Estate of E Gerald Kay F1, F5
transaction INBP Stock Option (right to buy) Award $0 +66,667 $0.000000 66,667 25 May 2023 Common Stock 66,667 $0.7200 As Co-Executor of the Estate of E Gerald Kay F1, F6
transaction INBP Stock Option (right to buy) Award $0 +21,667 $0.000000 21,667 25 May 2023 Common Stock 21,667 $1.04 As Co-Executor of the Estate of E Gerald Kay F1
transaction INBP Stock Option (right to buy) Disposed to Issuer $0 -50,000 -20% $0.000000 200,000 20 Sep 2023 Common Stock 50,000 $0.0900 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay.
F2 Closing price of the Issuer's Common Stock on March 20, 2023, date of transfer into the Estate of E Gerald Kay.
F3 3,410,512 as Co-Executor of the Estate of E Gerald Kay and 15,700 as Trustee to the Emily Sheppard Trust.
F4 50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
F5 25,000 vested on May 24, 2019 and 41,667 vested each May 24, 2020 and 2021 and 41,666 vested on May 24, 2022.
F6 33,334 vested on November 4, 2021, the one year anniversary of the grant date and 33,333 vested on November 4, 2022, the second year anniversary of the grant date.